The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential

mAbs

Volumn 5, Issue 4, 2013, Pages 587-594

  Clémenceau, Béatrice ^a,b   Vivien, Régine ^a   Pellat, Catherine ^a   Foss, Michael ^c   Thibault, Gilles ^c   Vié, Henri ^a,b  

^a Team 12   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

ADCC; CD16; Human; Lymphocyte; Mouse; NK; Transfection; Xenogenic

Indexed keywords

CD16 ANTIGEN; CD19 ANTIBODY; CD20 ANTIBODY; CD21 ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY SCREENING; ARTICLE; CELL SURFACE; DAUDI CELL; HUMAN; HUMAN CELL; MYELOMA CELL; NATURAL KILLER CELL; OPSONIZATION; PROTEIN EXPRESSION;

ADCC; CD16; HUMAN; LYMPHOCYTE; MOUSE; NK; TRANSFECTION; XENOGENIC;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODIES, NEOPLASM; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HUMANS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; MICE; MULTIPLE MYELOMA; RECEPTORS, IGG;

EID: 84880083909     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.25077     Document Type: Article

References (21)

1. Christiaansen JE, Burnside SS, Sears DW. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC). J Immunol 1987; 138:2236-43; PMID:3549899
2. Clémenceau B, Congy-Jolivet N, Gallot G, Vivien R, Gaschet J, Thibault G, et al. Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes. Blood 2006; 107:4669-77; PMID:16514054; http://dx.doi.org/10.1182/blood-2005-09-3775
3. Andrén M, Johanneson B, Alarcón-Riquelme ME, Kleinau S. IgG Fc receptor polymorphisms and association with autoimmune disease. Eur J Immunol 2005; 35:3020-9; PMID:16184517; http://dx.doi.org/10.1002/eji.200526291
4. Vivier E, Rochet N, Ackerly M, Petrini J, Levine H, Daley J, et al. Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms. Int Immunol 1992; 4:1313-23; PMID:1472481; http://dx.doi.org/10.1093/intimm/4. 11.1313
5. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8:652-8; PMID:8152260
6. Polyak MJ, Deans JP. Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure. Blood 2002; 99:3256-62; PMID:11964291; http://dx.doi.org/10.1182/blood.V99.9.3256
7. Teeling JL, Mackus WJ, Wiegman LJ, van den Brakel JH, Beers SA, French RR, et al. The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20. J Immunol 2006; 177:362-71; PMID:16785532
8. Overdijk MB, Verploegen S, Ortiz Buijsse A, Vink T, Leusen JH, Bleeker WK, et al. Crosstalk between human IgG isotypes and murine effector cells. J Immunol 2012; 189:3430-8; PMID:22956577; http://dx.doi.org/10.4049/jimmunol. 1200356
9. Anasetti C, Martin PJ, Morishita Y, Badger CC, Bernstein ID, Hansen JA. Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass. J Immunol 1987; 138:2979-81; PMID:2952730
10. Kipps TJ, Parham P, Punt J, Herzenberg LA. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 1985; 161:1-17; PMID:3918141; http://dx.doi.org/10.1084/jem.161.1.1
11. Würflein D, Dechant M, Stockmeyer B, Tutt AL, Hu P, Repp R, et al. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Cancer Res 1998; 58:3051-8; PMID:9679970
12. Junghans RP, Waldmann TA, Landolfi NF, Avdalovic NM, Schneider WP, Queen C. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res 1990; 50:1495-502; PMID:2406013
13. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83:435-45; PMID:7506951
14. Biburger M, Nimmerjahn F. Low level of FcγRIII expression on murine natural killer cells. Immunol Lett 2012; 143:53-9; PMID:22285694; http://dx.doi.org/10.1016/j.imlet.2012.01.002
15. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon. J Immunol 1979; 122:182-8; PMID:216746
16. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 1978; 273:759-61; PMID:566386; http://dx.doi.org/10.1038/273759a0
17. Brunda MJ, Rosenbaum D. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Cancer Res 1984; 44:597-601; PMID:6692364
18. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-17; PMID:17398124; http://dx.doi.org/10.1016/j.immuni.2007.03.006
19. Hooijberg E, van den Berk PC, Sein JJ, Wijdenes J, Hart AA, de Boer RW, et al. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model. Cancer Res 1995; 55:840-6; PMID:7531616
20. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, et al. Applications of retrovirus-mediated expression cloning. Exp Hematol 1996; 24:324-9; PMID:8641361
21. Swift S, Lorens J, Achacoso P, Nolan GP. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 2001; Chapter 10:Unit 10 7C. Médicale